glp 1 oral tablets FDA Approved: Orforglipron (Foundayo) — GLP-1 Drug • FDA approved for chronic weight management • Indicated for obesity and overweight with comorbidities • Oral, once-daily GLP-1 receptor agonist • First non-peptide A GLP-1 Pill May Help

A primary concern for menopausal GLP-1 users is the potential for accelerated bone thinning and muscle loss, which is why experts emphasize the necessity of a high protein intake and consistent strength training to mitigate these risks

Not for human or veterinary use, diagnosis, treatment, food, cosmetic, or household use

Related reading 4 mm vs 5 mm vs 6 mm Pen Needles for GLP-1 Injections: What the Evidence Says 4 mm is the modern default for GLP-1 self-injection

Remember, small, consistent changes in your eating habits can lead to significant long-term improvements in your metabolic health and quality of life

Modern GLP-1s like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have far more powerful effects